{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T07:48:17Z","timestamp":1788680897787,"version":"build-2803163510"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-159778"],"award-info":[{"award-number":["PJT-159778"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-469654"],"award-info":[{"award-number":["PJT-469654"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neuroinform."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Mathematical models serve as essential tools to investigate brain aging, the onset of Alzheimer's disease (AD) and its progression. By studying the representation of the complex dynamics of brain aging processes, such as amyloid beta (A\u03b2) deposition, tau tangles, neuro-inflammation, and neuronal death. Sensitivity analyses provide a powerful framework for identifying the underlying mechanisms that drive disease progression. In this study, we present the first local sensitivity analysis of a recent and comprehensive multiscale ODE-based model of Alzheimer's Disease (AD) that originates from our group. As such, it is one of the most complex model that captures the multifactorial nature of AD, incorporating neuronal, pathological, and inflammatory processes at the nano, micro and macro scales. This detailed framework enables realistic simulation of disease progression and identification of key biological parameters that influence system behavior. Our analysis identifies the key drivers of disease progression across patient profiles, providing insight into targeted therapeutic strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated a recent ODE-based model composed of 19 variables and 75 parameters, developed by our group, to study Alzheimer's disease dynamics. We performed single- and paired-parameter sensitivity analyses, focusing on three key outcomes: neural density, amyloid beta plaques, and tau proteins.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our findings suggest that the parameters related to glucose and insulin regulation could play an important role in neurodegeneration and cognitive decline. Second, the parameters that have the most important impact on cognitive decline are not completely the same depending on sex and APOE status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>These results underscore the importance of incorporating a multifactorial approach tailored to demographic characteristics when considering strategies for AD treatment. This approach is essential to identify the factors that contribute significantly to neural loss and AD progression.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fninf.2025.1590968","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T05:35:34Z","timestamp":1753248934000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Sensitivity analysis of a mathematical model of Alzheimer's disease progression unveils important causal pathways"],"prefix":"10.3389","volume":"19","author":[{"given":"Seyedadel","family":"Moravveji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Sadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Doyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Duchesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"B1","article-title":"A sensitivity analysis of a mathematical model for the synergistic interplay of amyloid beta and tau on the dynamics of Alzheimer's disease","author":"Bertsch","year":"2020","journal-title":"arXiv preprint arXiv:2006.01749"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1348113","DOI":"10.3389\/fninf.2024.1348113","article-title":"A computational model of Alzheimer's disease at the nano, micro, and macroscales","volume":"18","author":"Chamberland","year":"2024","journal-title":"Front. Neuroinform"},{"key":"B3","doi-asserted-by":"publisher","first-page":"100098","DOI":"10.1016\/j.brain.2024.100098","article-title":"Exploring tau protein and amyloid-beta propagation: a sensitivity analysis of mathematical models based on biological data","volume":"7","author":"Corti","year":"2024","journal-title":"Brain Multiphy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease\u2014the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat. Rev. Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/WNL.0000000000003234","article-title":"Relative effect of apoe e4 on neuroimaging biomarker changes across the lifespan","volume":"87","author":"Gonneaud","year":"2016","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12918-016-0348-2","article-title":"Mathematical model on Alzheimer's disease","volume":"10","author":"Hao","year":"2016","journal-title":"BMC Syst. Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3389\/fphar.2019.01222","article-title":"Isobologram analysis: a comprehensive review of methodology and current research","volume":"10","author":"Huang","year":"2019","journal-title":"Front Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1050777","DOI":"10.3389\/fnins.2022.1050777","article-title":"A transfer learning approach for multiclass classification of Alzheimer's disease using MRI images","volume":"16","author":"Khan","year":"2023","journal-title":"Front. Neurosci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.3390\/app12136507","article-title":"A practical multiclass classification network for the diagnosis of Alzheimer's disease","volume":"12","author":"Khan","year":"2022","journal-title":"Appl. Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The trem2-apoe pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0139574","DOI":"10.1371\/journal.pone.0139574","article-title":"Modeling the role of the glymphatic pathway and cerebral blood vessel properties in Alzheimer's disease pathogenesis","volume":"10","author":"Kyrtsos","year":"2015","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein e and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol"},{"key":"B13","first-page":"94","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"19","author":"Liu","year":"2023","journal-title":"Nat. Rev. Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/brain\/awy103","article-title":"Longitudinal brain imaging in preclinical Alzheimer disease: impact of apoe e4 genotype","volume":"141","author":"Mishra","year":"2018","journal-title":"Brain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1281656","DOI":"10.3389\/fninf.2024.1281656","article-title":"A scoping review of mathematical models covering Alzheimer's disease progression","volume":"18","author":"Moravveji","year":"2024","journal-title":"Front. Neuroinform"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e73631","DOI":"10.1371\/journal.pone.0073631","article-title":"Investigating interventions in Alzheimer's disease with computer simulation models","volume":"8","author":"Proctor","year":"2013","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/computation11080159","article-title":"Sensitivity analysis of mathematical models","volume":"11","author":"Sysoev","year":"2023","journal-title":"Computation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI124853","article-title":"APOE4-mediated amyloid-b pathology depends on its neuronal receptor LRP1","volume":"129","author":"Tachibana","year":"2019","journal-title":"J. Clin. Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1038\/s41467-024-49028-z","article-title":"Co-aggregation with apolipoprotein e modulates the function of amyloid-b in Alzheimer's disease","volume":"15","author":"Xia","year":"2024","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","article-title":"Apoe genotype alters glial activation and loss of synaptic markers in mice","volume":"60","author":"Zhu","year":"2012","journal-title":"Glia"}],"container-title":["Frontiers in Neuroinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fninf.2025.1590968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T05:35:35Z","timestamp":1753248935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fninf.2025.1590968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":21,"alternative-id":["10.3389\/fninf.2025.1590968"],"URL":"https:\/\/doi.org\/10.3389\/fninf.2025.1590968","relation":{},"ISSN":["1662-5196"],"issn-type":[{"value":"1662-5196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"article-number":"1590968"}}